Back

Hims Hers Health Inc

Ticker: HIMS ISIN: US4330001060
Add to portfolio Portfolio analysis in 2min
Stock Mid-cap High beta
Market cap
$6.33B
P/E
53.75
Forward P/E
64.52
Profit margin
5.47%
Revenue growth QoQ
28.40%
Beta
2.42
$27.85 -3.33%
Price as of 2026-09-15 · NYSE

Performance by timeframe

Rolling returns
1 Month -2.66%
6 Months +20.30%
1 Year -45.27%
5 Years +26.13% p.a.+219.01%
Since inception +16.08% p.a.+184.18%
Calendar year returns
YTD -14.23%
2025 +34.28%
2024 +171.69%
2023 +38.85%
2022 -2.14%
2021 -55.14%

Key stats

Market cap
6.33B
P/E
53.75
Beta
2.42
52-week range
13.74 - 70.43
50-day MA
22.07
200-day MA
37.32
Section 1

Business overview

Company profile data from fundamentals.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Country United States
Exchange NYSE
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 25.23%
ROA 5.29%
Profit margin 5.47%
Operating margin 2.72%
PEG ratio 2.36
Revenue/share TTM 10.44
Revenue TTM 2.35B
EBITDA 175.66M
Gross profit TTM 1.73B
Beta 2.42

Valuation

Trailing P/E 53.75
Forward P/E 64.52
P/B 11.71
P/S 2.70
EV/EBITDA 42.95
EV/Revenue 2.93
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 0.53
Quarterly earnings growth -17.40%
Revenue TTM 2.35B
Section 4

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Ownership & short interest

Short ratio 2.67
Short % of float 37.25%

Details

Instrument metadata and source update timestamps.

Symbol HIMS
Name Hims Hers Health Inc
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US4330001060
Country USA
Code + exchange HIMS.NYSE
Fundamentals updated 2026-05-04

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.